800 related articles for article (PubMed ID: 29950726)
1. High speed of fork progression induces DNA replication stress and genomic instability.
Maya-Mendoza A; Moudry P; Merchut-Maya JM; Lee M; Strauss R; Bartek J
Nature; 2018 Jul; 559(7713):279-284. PubMed ID: 29950726
[TBL] [Abstract][Full Text] [Related]
2. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
[TBL] [Abstract][Full Text] [Related]
3. CARM1 regulates replication fork speed and stress response by stimulating PARP1.
Genois MM; Gagné JP; Yasuhara T; Jackson J; Saxena S; Langelier MF; Ahel I; Bedford MT; Pascal JM; Vindigni A; Poirier GG; Zou L
Mol Cell; 2021 Feb; 81(4):784-800.e8. PubMed ID: 33412112
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Rad52-dependent replication fork recovery through serine ADP-ribosylation of PolD3.
Richards F; Llorca-Cardenosa MJ; Langton J; Buch-Larsen SC; Shamkhi NF; Sharma AB; Nielsen ML; Lakin ND
Nat Commun; 2023 Jul; 14(1):4310. PubMed ID: 37463936
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.
Hu K; Wu W; Li Y; Lin L; Chen D; Yan H; Xiao X; Chen H; Chen Z; Zhang Y; Xu S; Guo Y; Koeffler HP; Song E; Yin D
EMBO Rep; 2019 May; 20(5):. PubMed ID: 30940648
[TBL] [Abstract][Full Text] [Related]
6. Regulation of replication fork speed: Mechanisms and impact on genomic stability.
Merchut-Maya JM; Bartek J; Maya-Mendoza A
DNA Repair (Amst); 2019 Sep; 81():102654. PubMed ID: 31320249
[TBL] [Abstract][Full Text] [Related]
7. Tousled-like kinases stabilize replication forks and show synthetic lethality with checkpoint and PARP inhibitors.
Lee SB; Segura-Bayona S; Villamor-Payà M; Saredi G; Todd MAM; Attolini CS; Chang TY; Stracker TH; Groth A
Sci Adv; 2018 Aug; 4(8):eaat4985. PubMed ID: 30101194
[TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribosyl)ation of TIMELESS limits DNA replication stress and promotes stalled fork protection.
Rageul J; Lo N; Phi AL; Patel JA; Park JJ; Kim H
Cell Rep; 2024 Mar; 43(3):113845. PubMed ID: 38393943
[TBL] [Abstract][Full Text] [Related]
9. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
Zhang L; Li DQ
Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
[TBL] [Abstract][Full Text] [Related]
10. Mitotic functions of poly(ADP-ribose) polymerases.
Slade D
Biochem Pharmacol; 2019 Sep; 167():33-43. PubMed ID: 30910692
[TBL] [Abstract][Full Text] [Related]
11. Premature mitotic entry induced by ATR inhibition potentiates olaparib inhibition-mediated genomic instability, inflammatory signaling, and cytotoxicity in BRCA2-deficient cancer cells.
Schoonen PM; Kok YP; Wierenga E; Bakker B; Foijer F; Spierings DCJ; van Vugt MATM
Mol Oncol; 2019 Nov; 13(11):2422-2440. PubMed ID: 31529615
[TBL] [Abstract][Full Text] [Related]
12. PARP Activity Fine-tunes the DNA Replication Choreography of Chk1-depleted Cells.
Calzetta NL; González Besteiro MA; Gottifredi V
J Mol Biol; 2021 May; 433(10):166949. PubMed ID: 33744317
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting the MCM8-9 complex selectively sensitizes cancer cells to cisplatin and olaparib.
Morii I; Iwabuchi Y; Mori S; Suekuni M; Natsume T; Yoshida K; Sugimoto N; Kanemaki MT; Fujita M
Cancer Sci; 2019 Mar; 110(3):1044-1053. PubMed ID: 30648820
[TBL] [Abstract][Full Text] [Related]
14. PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors.
Parsels LA; Karnak D; Parsels JD; Zhang Q; Vélez-Padilla J; Reichert ZR; Wahl DR; Maybaum J; O'Connor MJ; Lawrence TS; Morgan MA
Mol Cancer Res; 2018 Feb; 16(2):222-232. PubMed ID: 29133592
[TBL] [Abstract][Full Text] [Related]
15. PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response.
Wurster S; Hennes F; Parplys AC; Seelbach JI; Mansour WY; Zielinski A; Petersen C; Clauditz TS; Münscher A; Friedl AA; Borgmann K
Oncotarget; 2016 Mar; 7(9):9732-41. PubMed ID: 26799421
[TBL] [Abstract][Full Text] [Related]
16. PARP-1 and its associated nucleases in DNA damage response.
Wang Y; Luo W; Wang Y
DNA Repair (Amst); 2019 Sep; 81():102651. PubMed ID: 31302005
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments.
Liao H; Ji F; Helleday T; Ying S
EMBO Rep; 2018 Sep; 19(9):. PubMed ID: 30108055
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.
Okuda A; Kurokawa S; Takehashi M; Maeda A; Fukuda K; Kubo Y; Nogusa H; Takatani-Nakase T; Okuda S; Ueda K; Tanaka S
BMC Neurosci; 2017 Jan; 18(1):14. PubMed ID: 28095779
[TBL] [Abstract][Full Text] [Related]
20. MBD1 protects replication fork stability by recruiting PARP1 and controlling transcription-replication conflicts.
Yu G; Xiong Y; Xu Z; Zhang L; Zhou XA; Nie C; Li S; Wang W; Li X; Wang J
Cancer Gene Ther; 2024 Jan; 31(1):94-107. PubMed ID: 37949945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
